CD274 and neoplasm: While these findings may support the relevance of PD-L1 as a surrogate biomarker of tumor aggressiveness and suggest its potential utility in risk stratification, they should be interpreted with caution, given the study’s limitations, including its retrospective design, limited sample size, and inability to support causal inferences.